Trial Profile
Efficacy of tafamidis in patients with transthyretin familial amyloid polyneuropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Tafamidis meglumine (Primary)
- Indications Amyloid polyneuropathy
- Focus Therapeutic Use
- 22 Aug 2016 New trial record